£104.01

It has never been this cheap. We have no record of a lower price.

£104 today · cheaper than every other day in the last 3 months

Peritoneal Carcinomatosis from Ovarian Cancer

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 27 days · 27 data points (no recent data)

Historical
Generating forecast…
£106.34 £103.78 £104.34 £104.90 £105.45 £106.01 £106.57 25 July 2026 31 July 2026 07 August 2026 13 August 2026 20 August 2026
View at Amazon ↗

Price data last checked 64 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 27 days • 2 price levels

Days at Price
Current Price
1 day · current 26 days 0 7 13 20 26 £104 £106 Days at Price

Price Analysis

Most common price: £106 (26 days, 96.3%)

Price range: £104 - £106

Price levels: 2 different prices over 27 days

Description

Ovarian cancer is the most common cause of death among all gynecological neoplasms. Ovarian epithelial cancer represents approximately 90% of all ovarian malignant tumours. The most usual pattern of spread and probably the earliest kind of metastasis of ovarian cancer is intraperitoneal spread, caused by apoptosis of viable cancer cells, even in cases where the ovarian surface has no visible rupture. Approximately 70% to 75% of all ovarian cancers are being diagnosed with peritoneal carcinomatosis and ascites in advanced stages III and IV. Peritoneal carcinomatosis from ovarian cancer may occur either concomitantly with the primary tumour or as a recurrence pattern of spread. Standard treatment consists of surgical debulking and postoperative systemic chemotherapy. Response rates to first-line chemotherapy with platinum/taxane combinations are high, about 70-80%, but the vast majority of patients will relapse. Peritoneal seeding is a major cause of surgical treatment failure among those patients, even after optimal debulking. However, progressing ovarian cancer tends to remain within the peritoneal cavity or, better-expressed, ovarian cancer is a cancer of the peritoneum. The administration of cytotoxic agents directly into the peritoneal cavity as treatment for malignancy was initially evaluated more than 40 years ago. Over the past two decades regional therapy of ovarian cancer has evolved from just an interesting pharmacokinetic concept into a viable management option for women with advanced disease. Several authors, and among them some of the world's leading experts on this field present the current knowledge and their experience on peritoneal carcinomatosis from ovarian cancer.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
08 April 2005
Listed Since
05 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy
96% match

Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy

Springer

£113.97 24 Sep 2026
Pathology of Peritoneal Metastases: The Unchartered Fields
96% match

Pathology of Peritoneal Metastases: The Unchartered Fields

Springer

£109.99 02 Sep 2026
Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics (Volume 21-4) (The Clinics: Surgery, Volume 21-4)
96% match

Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics (Volume 21-4) (The Clinics: Surgery, Volume 21-4)

Elsevier

£52.79 19 Sep 2026
Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)
96% match

Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)

Springer

£106.62 11 Aug 2026
Treatment of Peritoneal Surface Malignancies: State of the Art and Perspectives (Updates in Surgery)
96% match

Treatment of Peritoneal Surface Malignancies: State of the Art and Perspectives (Updates in Surgery)

Springer

£83.78 30 Sep 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
96% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£239.62 21 Aug 2026
Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)
96% match

Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)

Springer

£149.64 24 Sep 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
96% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£212.37 21 Aug 2026
A Practical Guide to Peritoneal Malignancy: The PMI Manual
96% match

A Practical Guide to Peritoneal Malignancy: The PMI Manual

CRC Press

£183.52 25 Aug 2026
A Practical Guide to Peritoneal Malignancy: The PMI Manual
96% match

A Practical Guide to Peritoneal Malignancy: The PMI Manual

CRC Press

£70.37 28 Aug 2026
Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)
96% match

Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)

Elsevier

£69.11 18 Sep 2026
Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond
96% match

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Springer

£75.34 22 Aug 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
95% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£39.33 14 Aug 2026
Peritoneal Surgery
95% match

Peritoneal Surgery

Springer

£94.20 14 Oct 2026
Peritoneal Surgery
95% match

Peritoneal Surgery

Springer

£150.58 13 Oct 2026
Pathology of the Ovary, Fallopian Tube and Peritoneum (Essentials of Diagnostic Gynecological Pathology)
95% match

Pathology of the Ovary, Fallopian Tube and Peritoneum (Essentials of Diagnostic Gynecological Pathology)

Springer

£99.99 18 Sep 2026
Pictorial Essays on Peritoneal Metastases Imaging: CT, MRI and PET-CT (New Developments in Medical Research)
95% match

Pictorial Essays on Peritoneal Metastases Imaging: CT, MRI and PET-CT (New Developments in Medical Research)

Price unavailable
PIPAC: Pressurized Intraperitoneal Aerosol Chemotherapy - Cancer Under Pressure (Phenomenology & Mind): 17
94% match

PIPAC: Pressurized Intraperitoneal Aerosol Chemotherapy - Cancer Under Pressure (Phenomenology & Mind): 17

De Gruyter

£104.99 03 Oct 2026
Pathology of the Ovary, Fallopian Tube and Peritoneum - Springer
94% match

Pathology of the Ovary, Fallopian Tube and Peritoneum - Springer

Springer

£140.60 14 Oct 2026
Intraperitoneal Therapy for Ovarian Cancer
94% match

Intraperitoneal Therapy for Ovarian Cancer

Springer

£106.59 20 Aug 2026
Peritonitis: Causes, Diagnosis and Treatment (Emergency and Intensive Care Medicine)
94% match

Peritonitis: Causes, Diagnosis and Treatment (Emergency and Intensive Care Medicine)

£72.99 06 Sep 2026
Surgical Management of Advanced Pelvic Cancer
94% match

Surgical Management of Advanced Pelvic Cancer

Wiley

£109.19 23 Aug 2026
Peritoneal Dialysis: 2 (Developments in Nephrology)
94% match

Peritoneal Dialysis: 2 (Developments in Nephrology)

Springer

£82.96 18 Sep 2026
Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)
93% match

Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)

Springer

£80.67 24 Sep 2026